These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 16253420

  • 1. Differential regulation of corticotropin-releasing factor receptor type 1 (CRF1 receptor) mRNA via protein kinase A and mitogen-activated protein kinase pathways in rat anterior pituitary cells.
    Moriyama T, Kageyama K, Kasagi Y, Iwasaki Y, Nigawara T, Sakihara S, Suda T.
    Mol Cell Endocrinol; 2005 Nov 24; 243(1-2):74-9. PubMed ID: 16253420
    [Abstract] [Full Text] [Related]

  • 2. Involvement of cAMP-response element binding protein in corticotropin-releasing factor (CRF)-induced down-regulation of CRF receptor 1 gene expression in rat anterior pituitary cells.
    Kasagi Y, Horiba N, Sakai K, Fukuda Y, Suda T.
    J Neuroendocrinol; 2002 Jul 24; 14(7):587-92. PubMed ID: 12121497
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures.
    Pozzoli G, Bilezikjian LM, Perrin MH, Blount AL, Vale WW.
    Endocrinology; 1996 Jan 24; 137(1):65-71. PubMed ID: 8536643
    [Abstract] [Full Text] [Related]

  • 6. Regulation of pituitary corticotropin releasing factor type-1 receptor mRNA binding proteins by modulation of the hypothalamic-pituitary-adrenal axis.
    Wu Z, Ji H, Hassan A, Aguilera G, Sandberg K.
    J Neuroendocrinol; 2004 Mar 24; 16(3):214-20. PubMed ID: 15049852
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta.
    Kageyama K, Furukawa K, Miki I, Terui K, Motomura S, Suda T.
    J Cardiovasc Pharmacol; 2003 Oct 24; 42(4):561-5. PubMed ID: 14508243
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity.
    Papadopoulou N, Chen J, Randeva HS, Levine MA, Hillhouse EW, Grammatopoulos DK.
    Mol Endocrinol; 2004 Mar 24; 18(3):624-39. PubMed ID: 14657255
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling.
    Jonassen AK, Wergeland A, Helgeland E, Mjøs OD, Brar BK.
    Regul Pept; 2012 Feb 10; 174(1-3):90-7. PubMed ID: 22209828
    [Abstract] [Full Text] [Related]

  • 13. Regulation of corticotropin-releasing factor receptor type 2beta messenger ribonucleic acid by interleukin-1beta in rat vascular smooth muscle cells.
    Kageyama K, Suda T.
    Neuroimmunomodulation; 2001 Feb 10; 9(6):326-32. PubMed ID: 12045360
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2.
    Van Kolen K, Dautzenberg FM, Verstraeten K, Royaux I, De Hoogt R, Gutknecht E, Peeters PJ.
    Neuropharmacology; 2010 Jan 10; 58(1):135-44. PubMed ID: 19573542
    [Abstract] [Full Text] [Related]

  • 18. Corticotropin-releasing factor up-regulates its own receptor gene expression in corticotropic adenoma cells in vitro.
    Sakai Y, Horiba N, Sakai K, Tozawa F, Kuwayama A, Demura H, Suda T.
    J Clin Endocrinol Metab; 1997 Apr 10; 82(4):1229-34. PubMed ID: 9100600
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.